| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.063 | 0.6 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |